83 related articles for article (PubMed ID: 24582479)
1. Novel dimeric Smac analogs as prospective anticancer agents.
Micewicz ED; Luong HT; Jung CL; Waring AJ; McBride WH; Ruchala P
Bioorg Med Chem Lett; 2014 Mar; 24(6):1452-7. PubMed ID: 24582479
[TBL] [Abstract][Full Text] [Related]
2. Lipid-conjugated Smac analogues.
Micewicz ED; Ratikan JA; Waring AJ; Whitelegge JP; McBride WH; Ruchala P
Bioorg Med Chem Lett; 2015 Oct; 25(20):4419-27. PubMed ID: 26384289
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of novel azapeptide activators of apoptosis mediated by caspase-9 in cancer cells.
Bourguet CB; Boulay PL; Claing A; Lubell WD
Bioorg Med Chem Lett; 2014 Aug; 24(15):3361-5. PubMed ID: 24986663
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582).
Hennessy EJ; Adam A; Aquila BM; Castriotta LM; Cook D; Hattersley M; Hird AW; Huntington C; Kamhi VM; Laing NM; Li D; MacIntyre T; Omer CA; Oza V; Patterson T; Repik G; Rooney MT; Saeh JC; Sha L; Vasbinder MM; Wang H; Whitston D
J Med Chem; 2013 Dec; 56(24):9897-919. PubMed ID: 24320998
[TBL] [Abstract][Full Text] [Related]
5. Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents.
Peng Y; Sun H; Lu J; Liu L; Cai Q; Shen R; Yang CY; Yi H; Wang S
J Med Chem; 2012 Jan; 55(1):106-14. PubMed ID: 22148838
[TBL] [Abstract][Full Text] [Related]
6. Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines.
Qamar S; Carrasquer CA; Cunningham SL; Cunningham AR
Anticancer Res; 2011 Oct; 31(10):3247-52. PubMed ID: 21965732
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and anticancer screening of some novel piperonyl-tetrazole derivatives.
Arshad M; Bhat AR; Pokharel S; Kim JE; Lee EJ; Athar F; Choi I
Eur J Med Chem; 2014 Jan; 71():229-36. PubMed ID: 24309000
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cell survival, cell cycle progression, tumor growth and cyclooxygenase-2 activity in MDA-MB-231 breast cancer cells by camphorataimide B.
Lin WL; Lee YJ; Wang SM; Huang PY; Tseng TH
Eur J Pharmacol; 2012 Apr; 680(1-3):8-15. PubMed ID: 22329896
[TBL] [Abstract][Full Text] [Related]
9. Smac mimetics as new cancer therapeutics.
Chen DJ; Huerta S
Anticancer Drugs; 2009 Sep; 20(8):646-58. PubMed ID: 19550293
[TBL] [Abstract][Full Text] [Related]
10. Anticancer versus antigrowth activities of three analogs of the growth-inhibitory peptide: relevance to physicochemical properties.
Mizejewski GJ; Eisele L; Maccoll R
Anticancer Res; 2006; 26(4B):3071-6. PubMed ID: 16886636
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel peptides through Ugi-ligation and their anti-cancer activities.
Tahoori F; Sheikhnejad R; Balalaie S; Sadjadi M
Amino Acids; 2013 Oct; 45(4):975-81. PubMed ID: 23864432
[TBL] [Abstract][Full Text] [Related]
12. Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation.
Ortuso F; Paduano F; Carotenuto A; Gomez-Monterrey I; Bilotta A; Gaudio E; Sala M; Artese A; Vernieri E; Dattilo V; Iuliano R; Brancaccio D; Bertamino A; Musella S; Alcaro S; Grieco P; Perrotti N; Croce CM; Novellino E; Fusco A; Campiglia P; Trapasso F
ACS Chem Biol; 2013 Jul; 8(7):1497-506. PubMed ID: 23627474
[TBL] [Abstract][Full Text] [Related]
13. Behavior-selective apoptotic capacity of 4-(3,4,5-Trimethoxyphenoxy) benzoic acid and its methyl derivatives on two breast cancer cell lines.
Lee KH; Ho WY; Wu SJ; Cheng TL; Huang PJ; Wang CC; Hung JH
Anticancer Res; 2014 Apr; 34(4):1801-9. PubMed ID: 24692713
[TBL] [Abstract][Full Text] [Related]
14. Anti-cancer activity of a novel palladium(II) complex on human breast cancer cells in vitro and in vivo.
Ulukaya E; Ari F; Dimas K; Ikitimur EI; Guney E; Yilmaz VT
Eur J Med Chem; 2011 Oct; 46(10):4957-63. PubMed ID: 21885165
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 2-phenyl-N-(5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl)acetamide derivatives as apoptosis inducers via the caspase pathway with potential anticancer activity.
Hosseinzadeh L; Khorand A; Aliabadi A
Arch Pharm (Weinheim); 2013 Nov; 346(11):812-8. PubMed ID: 24123162
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of the diarylthiourea analogs as novel anti-cancer agents.
Liu S; Louie MC; Rajagopalan V; Zhou G; Ponce E; Nguyen T; Green L
Bioorg Med Chem Lett; 2015 Mar; 25(6):1301-5. PubMed ID: 25701251
[TBL] [Abstract][Full Text] [Related]
17. Position of lipidation influences anticancer activity of Smac analogs.
Micewicz ED; Nguyen C; Micewicz A; Waring AJ; McBride WH; Ruchala P
Bioorg Med Chem Lett; 2019 Jul; 29(13):1628-1635. PubMed ID: 31047753
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53.
Mathiasen IS; Lademann U; Jäättelä M
Cancer Res; 1999 Oct; 59(19):4848-56. PubMed ID: 10519395
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Antitumor Activity of Novel 5-Pyridyl-1,3,4-oxadiazole Derivatives against the Breast Cancer Cell Line MCF-7.
Khalil NA; Kamal AM; Emam SH
Biol Pharm Bull; 2015; 38(5):763-73. PubMed ID: 25947922
[TBL] [Abstract][Full Text] [Related]
20. Gallic acid based steroidal phenstatin analogues for selective targeting of breast cancer cells through inhibiting tubulin polymerization.
Parihar S; Gupta A; Chaturvedi AK; Agarwal J; Luqman S; Changkija B; Manohar M; Chanda D; Chanotiya CS; Shanker K; Dwivedi A; Konwar R; Negi AS
Steroids; 2012 Jul; 77(8-9):878-86. PubMed ID: 22503714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]